MHM Magazine

S5 INIR 10 . Reg. No.: 43/1.2/0809. Each capsule contains atomoxetine hydrochloride equivalent to atomoxetine 10 mg. S5 INIR 18 . Reg. No.: 43/1.2/0810. Each capsule contains atomoxetine hydrochloride equivalent to atomoxetine 18 mg. S5 INIR 25 . Reg. No.: 43/1.2/0811. Each capsule contains atomoxetine hydrochloride equivalent to atomoxetine 25 mg. S5 INIR 40 . Reg. No.: 43/1.2/0812. Each capsule contains atomoxetine hydrochloride equivalent to atomoxetine 40 mg. S5 INIR 60 . Reg. No.: 43/1.2/0813. Each capsule contains atomoxetine hydrochloride equivalent to atomoxetine 60 mg. For full prescribing info please refer to package insert approved by the MCC. Dr. Reddy’s Laboratories (Pty) Ltd. Reg. No. 2002/014163/07. Tel: +27 11 324 2100 www.drreddys.co.za DISRUPTS THEIR LIVES AND FUNCTIONING References: 1. De Bruyckere K, Bushe C, Bartel C, Berggren L, Kan C, Dittmann R. Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/ Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database. CNS Drugs 2016; 30 :541–558. 2. Young JL, Sarkis E, Qiao M, Wietecha L. Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Clin Neuropharm 2011; 34 :51–60. 3. Lenzi F, Cortese S, Harris J, Masi G. Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis. Neurosci Biobehav Rev 2018; 84 :359–367. BUILD THEM UP AGAINWITH Restoring order to their lives 1,2,3